Enlightenment Research, LLC Astrazeneca PLC Transaction History

Enlightenment Research, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$59.26 - $71.14 $82,964 - $99,596	-1,400 Reduced 30.43%	3,200 $211,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $256,312 - $308,752	4,600 New	4,600 $305,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $581,040 - $722,160	-12,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$47.16 - $54.44 $565,920 - $653,280	12,000 New	12,000 $597,000
Q1 2019 May 03, 2019	SELL	$35.49 - $43.02 $489,762 - $593,676	-13,800 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$36.86 - $41.49 $508,668 - $572,562	13,800 New	13,800 $524,000

1,336

477M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.